Scientists have utilised AI to predict T cell receptors, advancing personalised medicine, and boosting immunotherapy and vaccine development.
A new research program will target biological causes and possible treatments, including anti-psychotic drugs, brain stimulation and hormones.
A class of drugs developed to treat type 2 diabetes and obesity is in short supply, sparking debate about who should be prioritised for access.
Professor Jamie Rossjohn is internationally recognised for using structural biology to investigate how T cells can respond to viral infections or cause autoimmunity. Now, he's been named a fellow of the oldest science academy in the world.
Research into snake venom pivoted from Alzheimer's disease to COVID-19 when the coronavirus reared its head.
Thomas Ko is spearheading innovative technology that takes injectable medicines and transforms them into pills.
Vaccination may one day allow coeliac disease sufferers to have their cake and eat it, too – but many questions remain unanswered.
After a horrific 2017 flu season, there's more interest than ever in developing a better, more universal vaccine. T-cells might hold the answer.
Dummy text
